Login
Navigate Fool.com
Will REGN beat
the market?
Community Rating: 2 Stars: Unattractive

299.87 -0.27 (-0.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $300.45
Previous Close $300.14
Daily Range $296.02 - $304.96
52-Week Range $203.70 - $352.49
Market Cap $30.0B
P/E Ratio 78.78
Dividend (Yield) $0.00 (0.0%)
Volume 256,906
Average Daily Volume 1,318,514
Current FY EPS $4.37

How do you think REGN
will perform against the market?

Top REGN Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted August 5, 2011

I took a chance and dumped out of Regeneron yesterday to preserve my positive score, and I was rewarded by escaping the 8% drop today as the tide went out. Unlike many of the other biotechs getting th … More

1 Replies Reply Report this Post
 

TMFUltraLong (< 20)
Submitted September 9, 2011

Very simply, I don't see Eylea being worth this much. Sure the data has shown its more effective than Avastin, but a $6.6 billion price tag and even in a utopian view maybe 10 times 2012 sales just se … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

Health Care Stocks: Check Out This Low-Cost Market Beater

These health care stocks have been growing by double digits. Should you buy?

Nasdaq 100 Movers: LLTC, YHOO

New Stock Coverage: Use (Don't Lose) Your Head in Regeneron

Wall Street ratings agencies set the tone for today's stock market.

Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?

Last week saw a widespread downturn among biotech stocks. Regeneron Pharmaceuticals, however, was able to move modestly higher. Why?

The Cost to Treat Cholesterol Plummets, But Will It Last?

Thanks to growing use of generics, spending on cholesterol treatments is falling. However, that may change once PCSK9 drugs from Amgen (AMGN), Regeneron (REGN), and Pfizer (PFE) reach the market.

Nasdaq 100 Movers: ISRG, REGN

Tweet of the Week: Big Biotech Dominates Industry Gains

Amgen, Biogen Idec, Celgene, Gilead Sciences, Regeneron Pharmaceuticals, and Alexion Pharmaceuticals make up 77% of the increase in the biotech sector over the past three years.

REGN Makes Notable Cross Below Critical Moving Average

Amgen, Inc. Pays GlaxoSmithKline plc (ADR) to Go Away

Amgen says goodbye to its Big Pharma partner.

Can This Drive Growth for Amarin Corporation plc?

A co-promotion agreement with Kowa seems like a reasonable way to drive badly-needed sales growth

See More REGN News...

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks